HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Vogt-Koyanagi-Harada disease and HLA type in Italian patients.

AbstractPURPOSE:
To study the frequencies of human leukocyte antigen (HLA) specificities in Italian patients with Vogt-Koyanagi-Harada disease and to correlate the presence of each specificity to the clinical features.
METHODS:
Human leukocyte antigen specificities were determined by standard microlymphocytotoxicity assay in 16 patients with Vogt-Koyanagi-Harada disease and compared with HLA specificities of 116 healthy controls.
RESULTS:
HLA-DR4 was statistically related to Vogt-Koyanagi-Harada disease (P = .0063), whereas only a trend toward a significant association between the disease and HLA-B41 was found (P = .06). HLA-DQ1 was detected in a disproportionate number of controls (68.9%) compared with patients (37.5%).
CONCLUSIONS:
HLA-DR4 was significantly related to Vogt-Koyanagi-Harada disease in Caucasian European patients, specifically in Italian patients, as it was described in other racial groups. No clear relation was found between the ophthalmologic and systemic manifestations of Vogt-Koyanagi-Harada disease and the presence of HLA specificities.
AuthorsP Pivetti-Pezzi, M Accorinti, R A Colabelli-Gisoldi, M P Pirraglia
JournalAmerican journal of ophthalmology (Am J Ophthalmol) Vol. 122 Issue 6 Pg. 889-91 (Dec 1996) ISSN: 0002-9394 [Print] United States
PMID8956647 (Publication Type: Journal Article)
Chemical References
  • Histocompatibility Antigens Class I
  • Histocompatibility Antigens Class II
Topics
  • Adult
  • Female
  • Histocompatibility Antigens Class I (immunology)
  • Histocompatibility Antigens Class II (immunology)
  • Histocompatibility Testing
  • Humans
  • Italy
  • Male
  • Uveomeningoencephalitic Syndrome (immunology)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: